| Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future. | |
| High Costs of Stem Cell Therapy: Will Stem Cell Firms Share in the Risk?
March 24, 2010 at 6:59 PM
|
| | Stem cell therapies are likely to be quite costly because of high development expenses and potentially high usage, according to a new report from the University of California at Berkeley, which said that new "financial risk-sharing mechanisms" could be needed. "The cost impact of the therapy is likely to be high, because of a therapy's high cost per patient, and the potentially large number of | | | | 
| This email was sent to agupta1213+termsc@gmail.com. Account Login
Don't want to receive this feed any longer? Unsubscribe here
This email was carefully delivered by Feed My Inbox. 230 Franklin Road Suite 814 Franklin, TN 37064 | |
No comments:
Post a Comment